EPIZYME

Ipsen's vision is to be a leading global mid-size biopharmaceutical company, with a focus on transformative medicines in three key therapeutic areas: oncology, rare disease and neuroscience... We are working to maximize the value of our core products. Our objective is to take patient-centricity to the next level by truly impacting medical care and patient outcomes in our therapeutic areas, notably by building a deep understanding of the patient journey. Patient insights are essential to challenge the status quo, while collaboration with healthcare systems can bring about advancements for patients around the world... Through our charitable contribution efforts, Ipsen provides donations to 501 (c)(3) organizations located in the US that are aligned with our company social responsibility priorities and focus on 1) a charitable mission is relevant to patients in Ipsen therapeutic area/s 2) location/city where Ipsen facility/ies and/or Ipsen colleagues live and/or work 3) supports Ipsen's..

Also known as: Ipsen, Ipsen US

Registration numbers: 47 095 036 909 (W)

Primary location: Springvale